Kyntra Bio (MEX:KYNB) EPS (Basic): MXN743.65 (TTM As of Mar. 2026)


MEX:KYNB Kyntra Bio Inc MEX:KYNB
45 GF Score
Price MXN118.50
GF Value MXN97.93
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Kyntra Bio EPS (Basic)?

Kyntra Bio MEX:KYNB 45 EPS (Basic) is MXN743.65 as of Mar. 2026. GuruFocus rates MEX:KYNB with a GF Score™ of 45/100 and a GF Value™ of MXN97.93 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Kyntra Bio's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was MXN-67.80. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN743.65.

Kyntra Bio's EPS (Diluted) for the three months ended in Mar. 2026 was MXN-67.80. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN743.65.

Kyntra Bio's EPS without NRI for the three months ended in Mar. 2026 was MXN-67.34. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -223.77.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Kyntra Bio  (MEX:KYNB) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Kyntra Bio EPS (Basic) Related Terms

Kyntra Bio EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Kyntra Bio's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyntra Bio EPS (Basic) Chart

Kyntra Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,610.35 -1,530.44 -1,239.12 -247.97 816.92

Kyntra Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.53 -35.40 910.06 -63.20 -67.80
MEX:KYNB
45GF Score
Kyntra Bio Inc MEX:KYNB
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyntra Bio EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Kyntra Bio's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3303.182-0)/4.043
=817.01

Kyntra Bio's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-274.061-0)/4.047
=-67.72

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN743.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of MXN743.65 mean?
Kyntra Bio (MEX:KYNB) has a EPS (Basic) of MXN743.65 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Kyntra Bio and its competitors.
Is Kyntra Bio's EPS (Basic) too high?
Kyntra Bio's current EPS (Basic) is MXN743.65. Overall, Kyntra Bio has a GF Score™ of 45/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kyntra Bio's EPS (Basic) compare to SER and SNSE?
Kyntra Bio's EPS (Basic) of MXN743.65 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Kyntra Bio and its competitors. Kyntra Bio's current EPS (Basic) is MXN743.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyntra Bio stock overvalued right now?
Based on GuruFocus' analysis, Kyntra Bio (MEX:KYNB) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN97.93, compared to a current price of MXN118.50 — trading 21% above its estimated fair value. The current EPS (Basic) is MXN743.65. Kyntra Bio's overall GF Score™ is 45/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Kyntra Bio (MEX:KYNB), the current EPS (Basic) is MXN743.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyntra Bio (MEX:KYNB) Overvalued in 2026?

Based on GuruFocus' analysis, Kyntra Bio stock appears to be overvalued. The current stock price of MXN118.50 is trading 21% above its estimated GF Value™ of MXN97.93. GuruFocus considers Kyntra Bio to be Modestly Overvalued.

Key valuation signals for MEX:KYNB:

  • EPS (Basic): MXN743.65
  • GF Value™: MXN97.93 vs. price of MXN118.50 (21% above fair value)
  • GF Score™: 45/100 with 8 warning signs

No single metric tells the full story. See the MEX:KYNB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kyntra Bio Business Description

Other Exchanges KYNB:USA0IL8:UK1FG0:Germany
Address 350 Bay Street, Suite 100, No. 6009, San Francisco, CA, USA, 94133
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
45GF Score

Get the complete analysis for MEX:KYNB

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN118.50
Price
MXN97.93
GF Value